Recent Quotes
My Watchlist
Indicators
Local Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Longboard Pharmaceuticals Inc (NQ: LBPH )

59.78 +0.05 (+0.08%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 13, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Longboard Pharmaceuticals Inc

< Previous 1 2 Next >
Deal Dispatch: Altus Power, Motorsport Games Explore Options, True Value Goes Bankrupt, M&A Activity Lags
S&P Global's Joe Mantone puts the latest M&A data in perspective and how deal pros might react post-Election Day. 
Via Benzinga
Topics Bankruptcy Stocks
Exposures Financial Legal US Equities
Oklo, CleanSpark And Wolfspeed Are Among Top 7 Mid Cap Gainers Last Week (Oct 14-18): Are The Others In Your Portfolio?
These seven mid-cap stocks were the best performers in the last week. Are they in your portfolio? 
Via Benzinga
Dow Surges Over 200 Points; Longboard Pharmaceuticals Shares Jump
Via Benzinga
Topics Stocks
Exposures US Equities
NVIDIA, Trump Media & Technology, Bausch + Lomb, Sirius XM And Other Big Stocks Moving Higher On Monday
Via Benzinga
Topics Government
Exposures Political
Recap: Longboard Pharmaceuticals Q4 Earnings
Via Benzinga
Looking Into Longboard Pharmaceuticals's Recent Short Interest
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Top 1% Biotech Longboard Scores A $2.6 Billion Deal And Skyrockets To A Record
Lundbeck will buy Longboard Pharmaceuticals in a deal slated to close in the fourth quarter. 
Via Investor's Business Daily
Why Is Epilepsy Focused Longboard Pharmaceuticals Stock Trading Higher On Monday?
H. Lundbeck acquires Longboard Pharmaceuticals for $2.6 billion. The acquisition strengthens Lundbeck's pipeline with bexicaserin, a potential treatment for Dravet syndrome and other neurological... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 47%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Starbucks To Rally More Than 22%? Here Are 10 Top Analyst Forecasts For Wednesday
Via Benzinga
Longboard Pharmaceuticals Boasts High-Value Epilepsy Assets, Analyst Initiates Coverage
Truist Securities initiated coverage on Longboard Pharmaceuticals, citing it as a CNS-focused biotech with high-value epilepsy assets. 
Via Benzinga
3 Russell 2000 Growth Stocks That Could Be Worth the Risk
These three small-cap stocks could deliver hefty returns if the central bank cuts rates. 
Via The Motley Fool
Topics Economy
Exposures Interest Rates
Top 3 Health Care Stocks That May Crash This Quarter
Via Benzinga
LBPH Stock Earnings: Longboard Pharmaceuticals Beats EPS for Q1 2024
LBPH stock results show that Longboard Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
Why Intel Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Intel Corporation (NASDAQ: INTC) fell sharply during Friday’s session. Intel reported upbeat results for its fourth quarter, but issued a weak forecast for the first quarter. 
Via Benzinga
Forget the "Magnificent Seven" -- This Stock Has Nearly Quadrupled in 2024, and Wall Street Thinks It Can Go a Lot Higher
You might say that this biotech stock is magnificent. 
Via The Motley Fool
Cantor Fitzgerald Maintains Overweight Rating for Longboard Pharmaceuticals: Here's What You Need To Know
Via Benzinga
Jim Cramer: This Energy Firm Has 'Good Growth, Good Yield' But As For IonQ? Ixnay
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Equitrans Midstream Corporation (NYSE: ETRN) is very solid. "Good growth, good yield. 
Via Benzinga
Why Longboard Pharmaceuticals Stock Is Falling
Longboard Pharmaceuticals Inc (NASDAQ: LBPH) shares are trading lower by 11.3% to $22.26 Wednesday afternoon after the company announced that it commenced a $150 million underwritten public offering... 
Via Benzinga
Apple, Longboard Pharmaceuticals, Coinbase, Moderna, Tesla: Why These 5 Stocks Are On Investors' Radars Today
U.S. stocks experienced mixed results in Tuesday’s trading session. The Dow Jones index showed resilience, gaining around 25 points, a modest rise of 0.07% to 37,715.04. In contrast, the tech-heavy... 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Longboard Pharma Catapulted 316%, Leading A Biotech Stock Rally
Longboard Pharmaceuticals is working on treatments for seizure disorders. 
Via Investor's Business Daily
Crude Oil Down 2%; Tesla Deliveries Top Estimates
U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite falling more than 250 points on Tuesday. The Dow traded up 0.01% to 37,691.77 while the NASDAQ fell 1.78% to... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
There's Optimism Around Longboard Pharmaceuticals' Anti-Seizure Candidate: Analyst Boosts Price Target
Tuesday, Longboard Pharmaceuticals Inc (NASDAQ: LBPH) released topline data from the PACIFIC Phase 1b/2a study evaluating bexicaserin (LP352) for seizures associated with a broad range of... 
Via Benzinga
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Longboard Pharmaceuticals, Inc. 
Via Benzinga
Why Is Longboard Pharmaceuticals (LBPH) Stock Up 175% Today?
With Longboard Pharmaceuticals delivering positive clinical trial data, LBPH stock soared on the positive therapeutic implications. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Dow Turns Higher; Anavex Life Sciences Shares Plunge
U.S. stocks traded mixed midway through trading, with the Dow Jones index gaining around 50 points on Tuesday. The Dow traded up 0.13% to 37,739.18 while the NASDAQ fell 1.29% to 14,818.23. The S&P 500... 
Via Benzinga
Topics Stocks
Exposures US Equities
Neurology-Focused Longboard Pharmaceuticals' Stock Soars Over 200% Today - Here's Why
Longboard Pharmaceuticals Inc (NASDAQ: LBPH) released topline data from the PACIFIC Phase 1b/2a study evaluating bexicaserin (LP352) for seizures associated with a broad range of Developmental  
Via Benzinga
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.